Publications
All Publications Recent Publications by Database MembersSubject
- Middle Aged10,349
- Aged, 80 and over7,101
- Risk Factors3,981
- Retrospective Studies3,687
- Cross-Sectional Studies2,799
- Alzheimer Disease2,731
- Cohort Studies2,655
- Prospective Studies2,570
- Mice2,097
- Young Adult2,065
Author
next >- Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study.
- Discordance Between Creatinine-Based and Cystatin C-Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR.
- Can exercise interventions reduce external knee adduction moment during gait? A systematic review and meta-analysis.
- Efficacy of emergency department calcium administration in cardiac arrest: A 9-year retrospective evaluation.
- Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial.
- Derivation and external validation of a risk score for clinically important declines in health and function among two longitudinal cohorts of women in the mid-life.
- Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF.
- Viruses - a major cause of amyloid deposition in the brain.
- Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy.
- High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease.
- Obesity and Undernutrition in Acute Myocardial Infarction.
- Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models.
- Analysis of Disparities in Time to Allogeneic Transplantation in Adults with Acute Myelogenous Leukemia.
- Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
- The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.
- The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial.
- Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
- Race or ethnicity and education in cardiac rehabilitation enrollment.
- Per- and Polyfluoroalkyl Substances (PFAS) and Lipid Trajectories in Women 45-56 Years of Age: The Study of Women's Health Across the Nation.
- The persistent inflammation, immunosuppression, and catabolism syndrome 10 years later.
pages:
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
more...
Next